
₹2,74,400(800 Shares)
Minimum Investment
IPO Dates
May 21, 2026 – May 25, 2026
Price Band
₹326–343 per equity share
Lot Size
400
Listing
May 29, 2026
Listing At
NSE SME
Overall Subscription
Total Bids Received
102.49x
Shares Offered
8,91,600
Shares Offered
11,88,000
Shares Offered
17,81,200
Shares Offered
20,79,200
Shares Offered
3,13,200
Founded in 2010, Q-Line Biotech Ltd. is involved in the development, manufacture and commercialization of various reagents (kits and POC devices) and consumables and manufacturing, importation, and su...
EPS (Pre-IPO)
16.47
EPS (Post-IPO)
22.12
P/E (Pre-IPO)
20.82
P/E (Post-IPO)
15.51
RoNW
16.88%
PAT Margin
16.65%
P/B Value
2.44
Market Cap
₹800.16 Cr.
* All figures are in ₹ Crores unless otherwise stated.
298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh - 226012.
Purva Sharegistry India Pvt Ltd
The Q-Line Biotech Limited IPO price band is set at ₹326.00 to ₹343.00 per equity share.
The lot size for Q-Line Biotech Limited IPO is 400 shares per lot. The minimum investment amount is approximately ₹1,37,200.
The Q-Line Biotech Limited IPO opens on May 21, 2026 and closes on May 25, 2026.
Q-Line Biotech Limited IPO is expected to be listed on May 29, 2026 on NSE SME.
The current GMP for Q-Line Biotech Limited IPO is ₹110, suggesting an expected listing price of around ₹436.00. Note: GMP is an unofficial market indicator.
The registrar for Q-Line Biotech Limited IPO is Purva Sharegistry India Pvt Ltd. You can contact them at newissue@purvashare.com.